Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living
MDBidNet Direct - MarylandStateOtherCloses in 2 days
Unlock the source link for this bid, plus email alerts when similar Other bids open in Maryland. 1,069 open bids in Maryland — see them all with your trial.